Company / Operating Margin
Immunocore Holdings plc Operating Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-11.3%
FY2025
5-year range
-29.7% / -11.3%
FY2022-FY2025
Trend
+50.1%
vs FY2024
Sector context
#61 of 136
Health Care
What the data says
At -11.3%, Immunocore Holdings plc's operating margin ranks #61 of 136 in the Health Care sector. Operating Margin has increased for 3 consecutive years, from -29.7% in FY2022 to -11.3% in FY2025.
Based on SEC 10-K filings.
-11.3% in FY2025 with a 3-year CAGR of +18.3%.
Improved from -23.9% to -11.3% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +18.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#61 of 136 in Health CareTop 45% of 136This company -11.3% Sector average -778.9%
▼
+98.5% above sector average
Key checks
Key Insights
- Immunocore Holdings plc's operating margin has grown for 3 consecutive years.
- In FY2025, operating margin increased 50.1% year-over-year.
- Currently 767.6pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -11.3% | +50.1% |
| FY2024 | -22.7% | +5.0% |
| FY2023 | -23.9% | +19.4% |
| FY2022 | -29.7% | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026